⏳ Fetching live dividend data...
Home › Calculator › XGN Dividend Calculator 2026
Exagen Inc. · NASDAQ
Price: $4.29 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in XGN → $982.8K in 10 years · $39,964.48/month
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by quantifying the level of B-cell C4d and erythrocyte bound C4d in the patient's blood; and AVISE APS, which consists of a panel of autoantibody tests that aids in the diagnosis and management of APS. In addition, it provides AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody and associated vasculitis; AVISE Anti-CarP test, which identifies RA patients with severe disease; and AVISE PC4d to measure platelet- bound C4d. Further, the company offers AVISE SLE Monitor, a biomarker blood test; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop novel patented biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open XGN position with:
Real after-tax yield depends on where you live and how you hold XGN.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 46.62% | 43.82% | $4,662 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 39.63% | 36.83% | $3,963 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 37.30% | 34.50% | $3,730 / yr |
| 🇬🇧 UK ISA | 0% | 46.62% | 43.82% | $4,662 / yr |
| 🇬🇧 UK Taxable | 8.75% | 42.54% | 39.74% | $4,254 / yr |
| 🇨🇦 TFSA | 0% | 46.62% | 43.82% | $4,662 / yr |
| 🇨🇦 CA Taxable | 25% | 34.96% | 32.16% | $3,496 / yr |
| 🇦🇺 Super (pension) | 15% | 39.63% | 36.83% | $3,963 / yr |
| 🇦🇺 AU Taxable | 30% | 32.63% | 29.83% | $3,263 / yr |
| 🇩🇪 DE Taxable | 26.375% | 34.32% | 31.52% | $3,432 / yr |
| 🇫🇷 FR Taxable | 30% | 32.63% | 29.83% | $3,263 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
XGN pays quarterly — 4 times per year. Next ex-div: TBD.
How XGN compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for XGN sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-02-27 | 1,511 | $3.08 | $4.6K | ||
| A-Award | 2026-03-12 | 75,000 | $3.16 | $237.0K | ||
| A-Award | 2026-03-12 | 50,000 | $3.16 | $158.0K | ||
| A-Award | 2026-03-12 | 150,000 | — | — | ||
| A-Award | 2026-03-12 | 100,000 | $3.16 | $316.0K | ||
| A-Award | 2026-03-03 | 2,535 | $3.08 | $7.8K | ||
| Sale | 2026-03-03 | 15,698 | $3.62 | $56.8K | ||
| Sale | 2026-02-24 | 11,430 | $3.61 | $41.3K | ||
| Sale | 2026-02-24 | 1,584 | $3.61 | $5.7K | ||
| Sale | 2025-10-16 | 31,787 | $11.82 | $375.6K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the XGN dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →